OMERS ADMINISTRATION Corp grew its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 308,197 shares of the semiconductor company’s stock after acquiring an additional 1,994 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Synopsys were worth $122,194,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Sankala Group LLC purchased a new position in Synopsys in the fourth quarter valued at approximately $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in Synopsys during the fourth quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys in the fourth quarter worth $28,000. Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys in the fourth quarter worth $32,000. Finally, Phillip James Consulting Co. purchased a new position in shares of Synopsys in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently weighed in on SNPS. Citigroup lifted their target price on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Stifel Nicolaus increased their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Benchmark began coverage on Synopsys in a research report on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price objective on the stock. Robert W. Baird set a $558.00 price objective on Synopsys in a research note on Thursday, May 28th. Finally, Rosenblatt Securities increased their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Synopsys has an average rating of “Moderate Buy” and a consensus target price of $570.06.
Synopsys Price Performance
Shares of SNPS stock opened at $373.47 on Friday. The firm has a fifty day simple moving average of $456.13 and a 200-day simple moving average of $455.25. The company has a market capitalization of $71.51 billion, a PE ratio of 86.45, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $651.73. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the firm posted $3.67 EPS. The firm’s quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Insider Activity
In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by company insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
